These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4000532)

  • 1. [Effect of tiropramide chlorhydrate on intestinal transit time in patients with irritable colon syndrome].
    Passaretti S; Fesce E; Fanti L; Bierti L; Bruno L; Rossini G; Mazzotti G; Ideo G; Tittobello A
    Minerva Med; 1985 May; 76(19-20):923-6. PubMed ID: 4000532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controlled clinical study on the efficacy of tiropramide hydrochloride in the treatment of irritable colon: comparison with octylonium bromide].
    Tinozzi S; Valesi MG
    Minerva Med; 1984 Jan; 75(1-2):23-31. PubMed ID: 6363985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in irritable colon. II. Repeated oral administration].
    Galeone M; Benazzi E; Bossi M; Moise G; Riva A; Stock F
    Pharmatherapeutica; 1986; 4(8):496-509. PubMed ID: 3714757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea.
    Chey WY; Jin HO; Lee MH; Sun SW; Lee KY
    Am J Gastroenterol; 2001 May; 96(5):1499-506. PubMed ID: 11374689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in the irritable colon: I. Administration by single i.v].
    Galeone M; Stock F; Moise G; Cacioli D; Benazzi E; Riva A
    Pharmatherapeutica; 1986; 4(7):445-56. PubMed ID: 3960945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome.
    Viramontes BE; Camilleri M; McKinzie S; Pardi DS; Burton D; Thomforde GM
    Am J Gastroenterol; 2001 Sep; 96(9):2671-6. PubMed ID: 11569693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy options for patients with irritable bowel syndrome.
    Talley NJ
    Am J Manag Care; 2001 Jul; 7(8 Suppl):S261-7. PubMed ID: 11474911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study.
    Lu CL; Chen CY; Chang FY; Lee SD
    Clin Sci (Lond); 1998 Aug; 95(2):165-9. PubMed ID: 9680498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS.
    Hasler WL; Saad RJ; Rao SS; Wilding GE; Parkman HP; Koch KL; McCallum RW; Kuo B; Sarosiek I; Sitrin MD; Semler JR; Chey WD
    Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1107-14. PubMed ID: 19808653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegaserod for the treatment of constipation-predominant irritable bowel syndrome.
    Baker DE
    Rev Gastroenterol Disord; 2001; 1(4):187-98. PubMed ID: 12120185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor effects of locally administered pinaverium bromide in the sigmoid tract of patients with irritable bowel syndrome.
    Passaretti S; Sorghi M; Colombo E; Mazzotti G; Tittobello A; Guslandi M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):47-50. PubMed ID: 2744907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are anticholinergics of use in the irritable colon syndrome?
    Ivey KJ
    Gastroenterology; 1975 May; 68(5 Pt 1):1300-7. PubMed ID: 1092588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in intestinal transit time induced by bromopride in functional diseases of the colon].
    Alvisi V; Pavani F; Loponte A; Ruina M; Tralli M; Tosi SP; Bagni B
    Minerva Med; 1981 Dec; 72(49):3337-40. PubMed ID: 7031516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome].
    Wittmann T; Fehér A; Rosztóczy A; Jánosi J
    Orv Hetil; 1999 Feb; 140(9):469-73. PubMed ID: 10204402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.